SynAct Pharma AB Cash Flow Reinvestment Rate
Latest as of June 2019:
0.22x
SynAct Pharma AB cash flow reinvestment rate. SynAct Pharma AB (SYNACT) has a Cash Flow Reinvestment Rate of 0.22x as of June 2019, reinvesting Skr394.90K (capex Skr394.90K ) from operating cash flow of Skr1.77 Million. Explore SynAct Pharma AB cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.22x
(Capex + Investments) / Operating CF
Total Reinvested
Skr394.90K
Capex + Investments
Operating Cash Flow
Skr1.77 Million
SEK
Capital Expenditures
Skr394.90K
SEK
SynAct Pharma AB Cash Flow Reinvestment Rate by Year (None–None)
SynAct Pharma AB cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for SynAct Pharma AB. For the full cash flow conversion analysis, see SYNACT cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow